Doximity, Inc. (NASDAQ:DOCS) Shares Bought by Apella Capital LLC

Apella Capital LLC grew its stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 14.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,039 shares of the company's stock after buying an additional 9,719 shares during the quarter. Apella Capital LLC's holdings in Doximity were worth $4,395,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in DOCS. Shaker Investments LLC OH purchased a new stake in Doximity in the 4th quarter worth $559,000. Principal Financial Group Inc. boosted its stake in shares of Doximity by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company's stock worth $15,695,000 after acquiring an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. purchased a new stake in shares of Doximity during the fourth quarter worth about $362,000. Stratos Wealth Partners LTD. bought a new stake in Doximity during the 4th quarter valued at approximately $203,000. Finally, Wells Fargo & Company MN raised its stake in Doximity by 3.3% during the 4th quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock valued at $19,698,000 after purchasing an additional 11,811 shares during the period. Institutional investors own 87.19% of the company's stock.

Doximity Trading Up 4.9%

Shares of DOCS traded up $2.69 during midday trading on Thursday, reaching $57.26. 2,713,313 shares of the stock were exchanged, compared to its average volume of 2,115,681. The company has a market capitalization of $10.75 billion, a P/E ratio of 57.26, a PEG ratio of 4.10 and a beta of 1.32. Doximity, Inc. has a 52 week low of $25.00 and a 52 week high of $85.21. The company's 50 day moving average is $54.70 and its two-hundred day moving average is $58.08.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The company's revenue was up 17.1% compared to the same quarter last year. During the same period last year, the firm earned $0.25 earnings per share. On average, sell-side analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Activity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now owns 16,618 shares of the company's stock, valued at $946,062.74. This represents a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the transaction, the chief financial officer now directly owns 357,165 shares in the company, valued at $20,440,552.95. This represents a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 51,000 shares of company stock worth $2,900,770. Corporate insiders own 37.40% of the company's stock.

Analysts Set New Price Targets

Several research analysts have weighed in on DOCS shares. Morgan Stanley dropped their price target on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research note on Thursday, April 24th. JPMorgan Chase & Co. cut their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research note on Tuesday, May 27th. Leerink Partnrs upgraded shares of Doximity from a "hold" rating to a "strong-buy" rating in a report on Friday, February 7th. KeyCorp decreased their price target on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Finally, Wells Fargo & Company restated an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Doximity has a consensus rating of "Moderate Buy" and an average price target of $62.84.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.